HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTAT

Formulations of the HIV compounds atazanavir and cobicistat such as tablet comprising atazanavir and cobicistat comprising having less than about 3% total cobicistat impurities after 8 weeks at 40 ° C and 75% relative humidity.

Saved in:
Bibliographic Details
Main Authors Koo, Otilia May Yue, Kottala, Niranjan Kumar, Nikfar, Faranak, Tao, Jing, Varia, Sailesh A
Format Patent
LanguageCroatian
English
Published 25.11.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Formulations of the HIV compounds atazanavir and cobicistat such as tablet comprising atazanavir and cobicistat comprising having less than about 3% total cobicistat impurities after 8 weeks at 40 ° C and 75% relative humidity.
Bibliography:Application Number: HR2022P001126T